Company
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
746 stories · page 32 of 38
London shares closed sharply higher on Friday and more than erased the previous session’s losses as two unlikely bedfellows – tobacco and pharma stocks – led the gains alongside a rebound by miners which had a difficult week
An unlikely combination of tobacco and drugs stocks are driving the top-share index's advance
London shares ended lower on Thursday as a robust manufacturing survey was interpreted as adding to production costs, rather than boosting exports in the wake of Britain’s vote to leave the European Union
M Pharmaceutical shares shot up more than 8% on Monday after the company released findings from the second of three proprietary pilot studies related to the recently acquired Chelatexx technology, referred to as the company's C-103 project
London shares closed lower on Thursday, nestled in negative territory throughout the session, as investors turned wary ahead of Fed chair Janet Yellen’s speech at Jackson Hole on Friday and pharma stocks were singed by Hillary Clinton’s pro
Mylan reacted by announcing plans to boost access to the product by expanding already-existing programs for patients who face what’s called out-of-pocket expenses.
Hilary Clinton took aim at one US drugs company - yet the shock waves were felt here in London.
Drug giant is setting up a new company, Galvani Bioelectronics, with Verily Life Sciences
London's blue-chip stocks ended lower on Thursday after a session spent mostly suspended beneath the previous closing level as investors sought safer haven in UK government bonds, or gilts
The FTSE 100 Index was 6.56 points adrift at 6,743.87 in lunchtime trading
The FTSE 100 Index was 3.2 points adrift at 6,747.24 in early trading
Builders and building materials
London blue-chip shares closed Wednesday at a more than one-year high, AIM paper had its best level in over two years, and mid-caps briefly beat pre-Brexit levels
Shares in GSK rose 25p, or 1.5%, to 1692p after it reported a 4% rise in group sales to £6.5bn
Sales rose by 4% in constant currencies and 11% in sterling terms to £6.5bn in the latest quarter.
Investments and investor services
The FTSE 100 Index rose 16.8 points to 6740.83 as second quarter UK GDP growth rose
Maker of iPhone likely to report slower device sales although services are tipped to have done well
London shares ended lower on Monday, as the weight of negative economic data finally overwhelmed a market propped up earlier in the session by takeover talk
William Hill gets takeover approach from Rank Group and 888
Investments and investor services
The FTSE 100 Index picked up 22.9 points to 6753.39
